Michael Aaron Kelly - Net Worth and Insider Trading

Michael Aaron Kelly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Aaron Kelly owns 6 companies in total, including Aprea Therapeutics Inc (APRE) , NeoGenomics Inc (NEO) , and DMC Global Inc (BOOM) among others .

Click here to see the complete history of Michael Aaron Kelly’s form 4 insider trades.

Insider Ownership Summary of Michael Aaron Kelly

Ticker Comapny Transaction Date Type of Owner
APRE Aprea Therapeutics Inc 2020-09-28 director
NEO NeoGenomics Inc 2020-07-15 director
BOOM DMC Global Inc 2020-07-24 director
HOOK HOOKIPA Pharma Inc 2019-04-17 director
FOLD Amicus Therapeutics Inc 2020-12-01 director
PRME Prime Medicine Inc 2022-10-19 director

Michael Aaron Kelly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Aaron Kelly Ownership Network

Ownership Network List of Michael Aaron Kelly

No Data

Ownership Network Relation of Michael Aaron Kelly


Michael Aaron Kelly Owned Company Details

What does Aprea Therapeutics Inc do?

Who are the key executives at Aprea Therapeutics Inc?

Michael Aaron Kelly is the director of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .

Aprea Therapeutics Inc (APRE) Insider Trades Summary

Over the past 18 months, Michael Aaron Kelly made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .

In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aprea Therapeutics Inc Insider Transactions

No Available Data

Michael Aaron Kelly Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Aaron Kelly. You might contact Michael Aaron Kelly via mailing address: C/o Hookipa Pharma Inc., 430 East 29th St., New York Ny 10016.

Discussions on Michael Aaron Kelly

No discussions yet.